AzTrials
AzTrials

Multiple SclerosisNCT05735691

High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis

A study testing High-Intensity Treadmill Training, Treadmill Training with Perturbations and Standard Treadmill Training in people with Multiple Sclerosis, run by Marquette University at 2 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to improve walking speed, balance, and walking in the community for people with multiple sclerosis. This trial involves intense exercise combined with walking on a shaky treadmill. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Multiple Sclerosis
What is being tested?
High-Intensity Treadmill Training, Treadmill Training with Perturbations and Standard Treadmill Training
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
2 sitesUnited States
Study dates
1 Jan 2023to 30 Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Participants must have a clinical diagnosis of MS according to the revised McDonald Criteria. Participants with an EDSS score of 2.0-6.5 will be included but must have a stable disease course without worsening more than 1.0 EDSS point over the last 3 months and no MS exacerbation within the preceding 4 weeks, as determined by interview and review of medical records.
  • Participants will have stable MS disease treatments. All medications will be consistent for at least 1 month prior to enrollment. No corticosteroids for at least 1 month and no botulinum toxin injections above the knee for at least 3 months prior to enrollment.
  • Participants will be between the age of 18 and 65 and have a body mass of less than 135kg (maximum mass for treadmill equipment).
  • Participants will be able to follow three commands, as determined by the three step command test of the Mini Mental State Exam.
  • Participants must have had no myocardial infarction in the past month, must not have uncontrolled hypertension (blood pressure must be < 190/110 mmHg at rest), must not have a symptomatic fall in blood pressure when standing and must not have documented, uncontrolled diabetes.
  • Participants will be medically stable, with absence of concurrent severe medical illness including: existing infection, known significant cardiovascular or metabolic disease that limits exercise participation, significant osteoporosis (as indicated by known history of fractures), known history of vascular claudication or pitting edema, and known history of pulmonary complications that limits exercise capacity, including significant obstructive and/or restrictive lung diseases.
Show all 13Show fewer
  • All participants must be able to perform walking training with passive range of motion within the limits of normal locomotor function, including: 0-30 +/- 10 degrees ankle plantarflexion, knee flexion from 0 to 90 +/- 10 degrees, hip flexion to 0-90 +/- 10 degrees.
  • Individuals who are undergoing concurrent physical therapy or supervised exercise by a trained professional will be excluded from the study to eliminate confounding effects of additional physical interventions. Other therapies, such as occupational or speech therapies, will be allowed as prescribed by their physician. Individuals will be allowed and encouraged to continue their normal exercise routines during the course of the intervention.
  • Participants must have no other concomitant neurological diseases, no history of epileptic seizures, peripheral nerve injury in lower legs or traumatic brain injury.
  • Participants must have adequate hearing (whisper test) and vision (minimum 20/80 corrected vision on a Snellen chart).
  • Participants must be able to walk for 10 meters at their preferred walking speed. For participants that require assistive devices to walk overground, minimal assistance will be provided to enable training until participants recover enough that they are not needed. The use of braces or orthoses is allowed in the proposed study to assure orthopedic safety. Participants will be excluded if they have factors that preclude stepping exercise, such as severe spasticity, excessive fatigue or exercise intolerance.
  • Women of childbearing potential will not be excluded, although women who are pregnant or who are considering becoming pregnant will be excluded due to the trunk and pelvis restraints required for safety during treadmill training.
  • Participants must be willing to commit to the treadmill training program schedule and participate in all of the assessments. They must be able to provide informed written consent and willing to be randomized to any of the 4 study arms.

Who cannot join

  • See inclusion criteria.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Brian D Schmit, PhD contact

4142886125

brian.schmit@marquette.edu

United States2 sites, 2 recruiting
  • Rehabilitation Hospital of Indiana

    Indianapolis, Indiana, 46254

    Thomas G Hornby, PhD, tghornby@iu.edu

    Recruiting
  • Marquette University

    Milwaukee, Wisconsin, 53233

    Brian D Schmit, PhD, 414-288-6125, brian.schmit@marquette.edu

    Recruiting

Other trials in United States

About this study

The goal of this clinical trial is to improve walking speed, balance, and walking in the community for people with multiple sclerosis. This trial involves intense exercise combined with walking on a shaky treadmill. Walking on a shaky treadmill helps to practice balance and intense exercise promotes the ability to walk faster and farther. In this study, participants will train with a combination of high or low intensity, and with a stable or shaky treadmill. Walking speed and endurance, balance while walking and the number of steps taken in the community will be measured before, half way through the training (15 sessions), after training (30 sessions) and six months after training.

Read the detailed description

This phase I/II clinical trial examines the effects of exercise intensity and balance perturbations on treadmill training in people with multiple sclerosis (MS). People with mild to moderate MS will be assigned to one of four treadmill training groups. One group will conduct treadmill training at a high exercise intensity with balance perturbations applied to the treadmill, a second group will undergo the same training at a low exercise intensity, a third group will conduct treadmill training at a high intensity with no perturbations and the fourth group will train at low intensity with no perturbations. The fourth group resembles typical clinical treadmill training paradigms. Each participant will undergo an initial screening to measure impairment (based on EDSS) and ability to follow three step directions. Demographic information will also be collected on each participant. Twenty participants will be assigned to each treatment group, with group assignment conducted randomly, balanced by severity of MS symptoms so that the impairment across groups is similar. The target sample size for this study was based on extensive previous studies examining high-intensity treadmill training in people with stroke or spinal cord injury, which show large effects compared to conventional treadmill training. In addition, data from a pilot study in people with MS demonstrated that perturbations applied during treadmill training have a large effect on postural stability while walking. The investigators expect that training intensity will impact gait speed and endurance, the use of perturbations will improve balance while walking, and both intensity and perturbations will improve stepping in the community.

The proposed training interventions will consist of up to 30 sessions of up to one hour of treadmill training over approximately 10 weeks. Each training session will consist of a warmup period and assessment of intensity, followed by four 10-minute intervals of treadmill stepping (as tolerated) with 2-3 minute rest intervals in between and a cool down at the end. In the groups receiving perturbations, movements will be applied to the treadmill every 7-20 seconds in random direction: right, left, forward or backward. Safety will be assured using a fall arrest harness, which is worn at all times. Perturbation size will be determined using a four-accelerometer system (right foot, left foot, sacrum and C7) to obtain an estimate of margin of stability for right/left perturbations and dynamic stability index for anterior/posterior directions. Training perturbation size will be increased until the stability reaches the stability threshold. This perturbation size will then be used for the training session. The intensity of the training will be controlled by monitoring heart rate. The target heart rate will be 70-80% of age-adjusted heart rate reserve for high intensity training and 30-40% of age-adjusted heart rate reserve for low intensity training. Care will be taken to maintain a cool environment, with monitoring of heart rate, rating of perceived exertion and step count. Depending on initial conditioning, participants may need to start with lower levels of exercise at the beginning of the training period and gradually increase until the target dose is achieved.

Assessments of walking function will be made at four times. The first assessment (Baseline) will be made before training begins, a second assessment will be made after 15 training sessions (Mid-Training), a third assessment will be made after training (Post-Training) and a follow up assessment will be made six months after training (Follow-Up). Each assessment will take approximately one hour to complete a series of clinical function tests and laboratory measures of gait function. Specifically, each assessment will consist of measurements of self-selected gait speed, gait endurance, peak treadmill speed, cardiorespiratory fitness and balance confidence. In addition, dynamic balance during gait will be measured using the response to balance perturbations. These measurements will be made using full body motion capture during a set of perturbations in each of the four perturbation directions. Kinematics of the response to the treadmill perturbations will be quantified including measures of foot placement, center of mass movement, with calculations of margin of stability and dynamic gait stability. Additional details of trunk and joint kinematics will be made as secondary measurements. At Baseline, Post-Training and Follow-Up, the investigators will also measure community stepping by issuing each participant a step counter for a 14-day period. The step counter will record the timing of steps throughout the day. When the participant returns, the steps count data will be downloaded and analyzed. Falls will be assessed at Baseline using a survey and each participant will be provided a journal to document falls, with phone contact every 4 weeks through Follow-Up. The study staff making the assessments will be blinded to the treatment group. The training staff and participant will not be able to be blinded to the treatment, since intensity of training and treadmill perturbations cannot be hidden from them. The statistician will be unblinded, as they will assign the participants to the treatment groups and conduct the statistical analysis on the measurements provided by the study staff.

The effects of training intensity will be assessed using measurements of gait speed and endurance. The investigators expect significant increases in these measurements with high-intensity compared to low-intensity training. Perturbation training is not expected to affect gait speed or endurance. Instead, the investigators expect that perturbation training will improve balance while walking. Training intensity is not expected to significantly affect balance. Both training intensity and perturbation training are expected to improve community mobility, measured by the number of steps per day. The investigators also expect secondary effects from high-intensity training to include improved cardiorespiratory fitness. Similarly, perturbation training is expected to have positive secondary effects on falls and balance confidence. All together, the investigators anticipate that improvements in community mobility provided by high-intensity perturbation treadmill training will improve quality of life in people with MS.

Being tested
High-Intensity Treadmill Training, Treadmill Training with Perturbations, Standard Treadmill Training
Keywords
Walking, Balance, Treadmill, Exercise
Medical subject headings
Multiple Sclerosis, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • High-Intensity Treadmill TrainingProcedure or surgery

    Participants will walk on a treadmill at a speed that produces 70-80% of age-adjusted heart rate reserve or a rating of perceived exertion of 17/20. A total of 30, one hour sessions will be conducted. Training will be conducted in 10 minute bouts, with 2-3 minutes rest between bouts.

  • Treadmill Training with PerturbationsProcedure or surgery

    Participants will walk on a treadmill and a perturbation of the treadmill will be produced every 20s. Perturbations will randomly occur in the forward, backward, right or left directions, with a perturbation size set to 80% of stability threshold. A total of 30, one hour sessions will be conducted. Training will be conducted in 10 minute bouts with 2-3 minutes rest between bouts.

  • Standard Treadmill TrainingProcedure or surgery

    Participants will walk on a treadmill at a speed that produces 30-40% of age-adjusted heart rate reserve. A total of 30, one hour sessions will be conducted. Training will be conducted in 10 minute bouts, with 2-3 minutes rest between bouts.

Study groups in NCT05735691
Study groupRoleWhat they receive
High-Intensity With PertubationsExperimental30 sessions of high-intensity treadmill training will be conducted. Perturbations that disrupt balance will be applied during the training.
Receives: Procedure: High-Intensity Treadmill Training; Procedure: Treadmill Training with Perturbations
High-Intensity No PerturbationsExperimental30 sessions of high-intensity treadmill training will be conducted on a stable treadmill.
Receives: Procedure: High-Intensity Treadmill Training
Moderate-Intensity With PerturbationsExperimental30 sessions of moderate-intensity treadmill training will be conducted. Perturbations that disrupt balance will be applied during the training.
Receives: Procedure: Treadmill Training with Perturbations; Procedure: Standard Treadmill Training
Moderate-Intensity No PerturbationsActive comparator30 sessions of moderate-intensity treadmill training will be conducted on a stable treadmill.
Receives: Procedure: Standard Treadmill Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in Timed 25-foot walk test

    Gait speed will be measured using the timed 25-foot walk test. The test consists of walking 25 feet along a clearly marked walkway as quickly as possible while maintaining safety, using devices as needed. The task is repeated as the patient walks back the same distance. The average of the two trials is used as a measure of gait speed.

    Measured: Before training, 5-6 weeks after training begins, 1-2 weeks after all training sessions, 6 months after all training sessions

  2. Changes in 6-minute walk test

    The 6 minute walk test consists of a measurement of the distance walked in 6 minutes, using a walkway of at least 12 meters, with cones demarcating the turnaround points and instructions to walk as fast and as far as possible.

    Measured: Before training, 5-6 weeks after training begins, 1-2 weeks after all training sessions, 6 months after all training sessions

  3. Changes in Functional Gait Assessment (FGA)

    The FGA measures dynamic balance during walking using a series of 10 tasks, with each item rated on a scale of 0-3 (maximum score = 30). Test components include walking on a level surface at normal pace with changes in gait speed, head turns, obstacle and narrow path negotiation, and on stairs.

    Measured: Before training, 5-6 weeks after training begins, 1-2 weeks after all training sessions, 6 months after all training sessions

  4. Changes in Daily stepping activity

    Daily stepping activity will be obtained using the StepWatch (Modus, Washington DC), which is an ankle-worn accelerometer that has demonstrated the best accuracy of all commercial accelerometers. Data are collected in 1 min increments with daily stepping activity as the primary variable. Data will be collected for 7 days at each evaluation period.

    Measured: Before training, 1-2 weeks after all training sessions, 6 months after all training sessions

Secondary outcomes (9)
  1. Changes in Peak treadmill speed and cardiorespiratory fitness

    VO2peak and VO2gain ml/mg/min will be assessed during graded treadmill testing. Participants will walk at 0.1 m/s for 1 min, with speed increased by 0.1 m/s every minute. Metabolic data will be collected on a breath-by-breath basis until treadmill testing is terminated, as determined by loss of balance, patient intolerance, or abnormal ECG recording consistent with absolute contraindications to continue testing. The averaged VO2 during the final minute of treadmill testing at peak speed will be determined (VO2peak). Baseline VO2peak and VO2 at the matched speed Post-training (VO2match) will be used to identify changes in metabolic efficiency. The difference between gains in VO2peak and VO2match will be identified as VO2 gain.

    Measured: Before training, 5-6 weeks after training begins, 1-2 weeks after all training sessions, 6 months after all training sessions

  2. Changes in Berg Balance Scale

    The Berg Balance Scale (BBS) will be used to assess standing balance and determine whether walking balance training carries over to standing balance. The BBS consists of 14 static and dynamic balance tasks of varying difficulty, rated on a scale of 0-4 by an assessor (max score = 56).

    Measured: Before training, 5-6 weeks after training begins, 1-2 weeks after all training sessions, 6 months after all training sessions

  3. Changes in Falls incidence

    A survey of Falls incidence will be administered at Baseline to estimate the number of falls in the past 6 months. At this time, participants will be issued a journal to document falls for the duration of the training study and for 6 months after training has been completed. Study staff will contact participants every month to assure compliance.

    Measured: Before training, 5-6 weeks after training begins, 1-2 weeks after all training sessions, 6 months after all training sessions

  4. Changes in Kinematic Response to unexpected perturbations

    Responses to 5 magnitudes of perturbations of the treadmill in 4 directions will be measured using a whole body motion capture. Center of Mass movement and foot placement (Base of Support) will be calculated and medial/lateral margin of stability and anterior/posterior dynamic gait stability will be used to assess the response. Step sizes and trunk angles will be quantified.

    Measured: Before training, 5-6 weeks after training begins, 1-2 weeks after all training sessions, 6 months after all training sessions

  5. Changes in Activities-specific Balance Confidence (ABC) score

    The ABC is a self-report on 16 items, with each item beginning with the phrase 'How confident are you that you will not lose your balance or become unsteady when you ….'. Each item is rated from a score of 0 (no confidence) to 100 (complete confidence) and the items are averaged to obtain a score (max =100)

    Measured: Before training, 5-6 weeks after training begins, 1-2 weeks after all training sessions, 6 months after all training sessions

  6. Changes in Medical Outcomes Short-Form 36 (SF-36) Version 2

    The Medical Outcomes Short-Form 36 (SF-36) is a 36-item questionnaire that is divided into 8 subscales and 2 composite domains (SF-36-Physical and SF-36-Mental) and consists of Likert-type items that assess subjective physical and mental capacity and well-being over the past 4 weeks. Scales are standardized by the SF-36v2 scoring software to obtain a score ranging from 0 to 100 with higher scores indicating better health status.

    Measured: Before training, 5-6 weeks after training begins, 1-2 weeks after all training sessions, 6 months after all training sessions

  7. Changes in Peak Stepping Rate

    Stepping activity from the StepWatch will be collected and analyzed to assess the pattern of community stepping. Secondary measures of stepping activity will include peak stepping rate (steps/min).

    Measured: Before training, 1-2 weeks after all training sessions, 6 months after all training sessions

  8. Changes in Total Bouts of Stepping

    Stepping activity from the StepWatch will be collected and analyzed to assess the pattern of community stepping. Secondary measures of stepping activity will include total bouts of stepping.

    Measured: Before training, 1-2 weeks after all training sessions, 6 months after all training sessions

  9. Changes in Average Duration of Stepping Bouts

    Stepping activity from the StepWatch will be collected and analyzed to assess the pattern of community stepping. Secondary measures of stepping activity will include average duration of stepping bouts (i.e., bout = period of stepping without rest).

    Measured: Before training, 1-2 weeks after all training sessions, 6 months after all training sessions

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2023
  2. Study start1 Jan 2023
  3. Primary completion30 Jun 2027 (estimated)
  4. Study completion30 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Model description
A 2x2 factorial design will be used. One factor will consist of high intensity vs moderate intensity. The second factor will be walking perturbations vs no perturbations.
Masking
Triple blind
Who is masked
Care provider, Investigator, Outcomes assessor
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05735691
Sponsor's protocol ID
4257
Other IDs
R01HD107145
Status last verified
Jun 2024
First submitted
11 Jan 2023
Last updated
5 Jun 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The investigators will share phenotypic data associated with the collected samples by depositing data at clinicaltrials.gov. Additional data documentation and de-identified data will be deposited for sharing along with phenotypic data. Meta-analysis data and associated phenotypic data, along with data content, format, and organization, will be available via contact of the PI (brian.schmit@marquette.edu). We will identify where the data will be available and how to access the data in any publications and presentations that we author or co-author about these data, as well as acknowledge the repository and funding source in any publications and presentations.

Questions about this trial

What is this clinical trial studying?

A study testing High-Intensity Treadmill Training, Treadmill Training with Perturbations and Standard Treadmill Training in people with Multiple Sclerosis, run by Marquette University at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 13 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Brian D Schmit, PhD (4142886125, brian.schmit@marquette.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in Timed 25-foot walk test (time frame: Before training, 5-6 weeks after training begins, 1-2 weeks after all training sessions, 6 months after all training sessions). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT05735691 | AzTrials